William Tai-Wei Ho - 13 Dec 2023 Form 4 Insider Report for IN8BIO, INC. (INAB)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
INAB
Transactions as of
13 Dec 2023
Net transactions value
$0
Form type
4
Filing time
15 Dec 2023, 08:24:30 UTC
Previous filing
28 Aug 2023
Next filing
08 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INAB Common Stock Award +81,967 +3.5% 2,421,512 13 Dec 2023 Direct F1
holding INAB Common Stock 72,999 13 Dec 2023 By child
holding INAB Common Stock 73,000 13 Dec 2023 By child
holding INAB Common Stock 36,500 13 Dec 2023 See footnote F2
holding INAB Common Stock 36,500 13 Dec 2023 See footnote F2
holding INAB Common Stock 36,500 13 Dec 2023 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INAB Series A Warrants (right to buy) Award +81,967 81,967 13 Dec 2023 Common Stock 81,967 $1.25 Direct F1, F3
transaction INAB Series B Warrants (right to buy) Award +81,967 81,967 13 Dec 2023 Common Stock 81,967 $1.50 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock.
F2 The shares are held by a relative of the Reporting Person. The Reporting Person has voting power pursuant to a voting proxy.
F3 Fully vested and exercisable.